InsiderClue
Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

Ceribell, Inc.

CBLL Clue Score52
United States Fiscal year ends December CIK 0001861107
$25.26 +6.90% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $25.26 +110.85% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 11 Oct 2024. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2023Revenue45.2Operating income−30.0Net income−29.5EPS, diluted−5.56Fiscal year 2024Revenue65.4 +44.7%Operating income−39.7Net income−40.5EPS, diluted−3.39Fiscal year 2025Revenue89.1 +36.1%Operating income−58.4Net income−53.4EPS, diluted−1.46
FY2023FY2024FY2025
Revenue 45.2 65.4 89.1
Growth +44.7% +36.1%
Operating income −30.0 −39.7 −58.4
Net income −29.5 −40.5 −53.4
Growth
EPS, diluted −5.56 −3.39 −1.46

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2023Gross margin84.4%Operating margin−66.4%Net margin−65.1%Free cash flow margin−66.6%Fiscal year 2024Gross margin86.7%Operating margin−60.7%Net margin−61.8%Free cash flow margin−55.6%Fiscal year 2025Gross margin87.9%Operating margin−65.6%Net margin−60.0%Free cash flow margin−46.7%
FY2023FY2024FY2025
Gross margin 84.4% 86.7% 87.9%
Operating margin −66.4% −60.7% −65.6%
Net margin −65.1% −61.8% −60.0%
Free cash flow margin −66.6% −55.6% −46.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2023Operating cash flow−29.2Capital expenditure−1.0Free cash flow−30.1Fiscal year 2024Operating cash flow−35.0Capital expenditure−1.3Free cash flow−36.4Fiscal year 2025Operating cash flow−40.8Capital expenditure−0.8Free cash flow−41.6
FY2023FY2024FY2025
Operating cash flow −29.2 −35.0 −40.8
Capital expenditure −1.0 −1.3 −0.8
Free cash flow −30.1 −36.4 −41.6
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2023Cash34.5Shareholders’ equity−112.3Fiscal year 2024Cash194.4Shareholders’ equity191.2Fiscal year 2025Cash40.5Shareholders’ equity155.3
FY2023FY2024FY2025
Cash 34.5 194.4 40.5
Shareholders’ equity −112.3 191.2 155.3

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
84.4% 86.7% 87.9%
−66.4% −60.7% −65.6%
−65.1% −61.8% −60.0%
−65.1% −61.8% −60.0%
−66.6% −55.6% −46.7%
Spending
19.9% 20.7% 21.5%
44.9% 51.7% 49.9%
2.2% 2.0% 0.9%
Returns
n/a −21.2% −34.4%
−50.0% −17.9% −27.3%
Balance and payout
40.3% 15.2% 20.7%